Transaction will Strengthen Kane’s Wound Care and Dermatology Portfolio and Expand Global Commercial Reach WINNIPEG, Manitoba, Nov. 12, 2024 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company”, “Kane Biotech”) announce
Transaction will Strengthen Kane’s Wound Care and Dermatology Portfolio and Expand Global Commercial Reach Read More